Adalimumab for Corticosteroid and Infliximab-Resistant Immune Reconstitution Inflammatory Syndrome in the Setting of TB/HIV Coinfection
Open Access
- 30 January 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 5 (2) , ofy027
Abstract
Corticosteroids are the mainstay of therapy for immune reconstitution inflammatory syndrome (IRIS). However, little is known about how to treat IRIS unresponsive to steroids. We report a patient with HIV-TB coinfection who was unresponsive to first prednisolone and then infliximab but whose IRIS resolved with adalimumab.Keywords
This publication has 14 references indexed in Scilit:
- Tuberculosis-immune reconstitution inflammatory syndromeJournal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2016
- Treatment with adalimumab for severe immune reconstitution inflammatory syndrome in an HIV-infected patient presenting with cryptococcal meningitisMedecine Et Maladies Infectieuses, 2016
- A Paradoxical Treatment for a Paradoxical Condition: Infliximab Use in Three Cases of Mycobacterial IRISClinical Infectious Diseases, 2015
- Anti-tumor necrosis factor monoclonal antibody for steroid-dependent TB-IRIS in AIDSAIDS, 2015
- Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort studyThe Lancet Infectious Diseases, 2015
- Which Antipsoriatic Drug Has the Fastest Onset of Action?—Systematic Review on the Rapidity of the Onset of ActionJournal of Investigative Dermatology, 2013
- Adalimumab treatment may replace or enhance the activity of steroids in steroid-refractory tuberculous meningitisJournal of Infection and Chemotherapy, 2012
- Treatment of HIV‐Related Inflammatory Cerebral Cryptococcoma with AdalimumabClinical Infectious Diseases, 2010
- Neurologic Manifestations of Paradoxical Tuberculosis‐Associated Immune Reconstitution Inflammatory Syndrome: A Case SeriesClinical Infectious Diseases, 2009
- Therapeutic Use of Infliximab in Tuberculosis to Control Severe Paradoxical Reaction of the Brain and Lymph NodesClinical Infectious Diseases, 2008